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In her recent commentary, Doctor Ross [1] puts forth a series
of cogent arguments in favor of careful study of partial breast
irradiation before its generalized use. The title of the
commentary, particularly the phrase ‘who will benefit’, begs a
different perspective than the presentation of existing data for
or against the use of any given therapy. Instead, the question
asks for a more profound view of the role of any health care
provider within any health care system in helping a patient to
deal with the medical, social, psychological and financial
impact of a disease process.
Just as it is an acceptable option to undergo mastectomy
when breast conservation is an option, it is also felt to be
acceptable to choose lumpectomy alone if the patient
understands the potential for increased local recurrence. In
the trial conducted by Fyles and coworkers [2], perhaps more
patients would have accepted randomization after
lumpectomy if the radiotherapy arm were 1 week instead of 6.
In the USA the patient is given options and, hopefully, the
background to understand them. Partial breast irradiation is
an option that appears to be roughly equivalent to whole
breast irradiation for carefully selected, carefully treated
patients. I agree that the ongoing phase III randomized trials
in Europe and the USA are important in further refining and
developing our knowledge of these newer treatment options.
The US study has elaborate quality of life end-points and will
shed light on patient’s experiences with both whole and
partial breast irradiation. Furthermore, by having broad
eligibility requirements, the study may help to delineate which
patients are ideal condidates for partial breast treatment.
Even after the trials are complete and the data mature, the
question will remain because some patients will benefit from
different options depending on their particular situation,
whether that situation is a medical/pathologic or a
psychosocial one. The treating physician will have more
information to share with their patients, and will be better able
to guide them in making an appropriate choice. Does that
mean that partial breast irradiation is an invalid choice now in
an appropriately informed patient? I’d say ‘no’.
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